tirzepatide ruling january 2025 Lilly, Novo Fight Weight Loss Drug Compounders Over Shortage Tirzepatide compounded: Can you still
Description
Most older weight-loss medications only work on one of these pathways
Tirzepatide is developed by Eli Lilly, while Semaglutide (Ozempic) is developed by Novo Nordisk
This combined action results in improved glycemic control and significant weight loss in clinical trials
The FDA approved tirzepatide for managing type 2 diabetes under the brand name Mounjaro
results are expected from large trials, but definitive FDA indications were not established at the time of this writing
